Xencor Inc
F:XE9
Xencor Inc
F:XE9
Price:
10.3
EUR
1.98%
Market Closed
Market Cap:
€634.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
X
|
Xencor Inc
F:XE9
|
US |
|
P
|
Pfizer Inc
SGO:PFE
|
US |
Balance Sheet
Balance Sheet Decomposition
Xencor Inc
Xencor Inc
Balance Sheet Decomposition is not available for
Xencor Inc
Xencor Inc
Balance Sheet
Xencor Inc
Xencor Inc
Currency: USD
| Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||
| Cash & Cash Equivalents |
15
|
2
|
78
|
55
|
13
|
15
|
17
|
26
|
50
|
164
|
144
|
54
|
54
|
41
|
54
|
|
| Cash Equivalents |
15
|
2
|
78
|
55
|
13
|
15
|
17
|
26
|
50
|
164
|
144
|
54
|
54
|
41
|
54
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
84
|
116
|
208
|
268
|
480
|
440
|
191
|
569
|
540
|
457
|
494
|
|
| Total Receivables |
0
|
0
|
0
|
3
|
0
|
9
|
1
|
11
|
22
|
24
|
66
|
29
|
24
|
61
|
29
|
|
| Accounts Receivables |
0
|
0
|
0
|
3
|
0
|
9
|
1
|
10
|
22
|
24
|
66
|
29
|
24
|
61
|
29
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
3
|
6
|
10
|
7
|
11
|
24
|
23
|
18
|
19
|
23
|
|
| Total Current Assets |
15
|
3
|
78
|
58
|
98
|
142
|
231
|
316
|
558
|
638
|
424
|
675
|
636
|
578
|
600
|
|
| PP&E Net |
0
|
0
|
0
|
1
|
2
|
3
|
7
|
12
|
25
|
32
|
60
|
94
|
100
|
98
|
91
|
|
| PP&E Gross |
0
|
0
|
0
|
1
|
2
|
3
|
0
|
12
|
25
|
32
|
60
|
94
|
100
|
98
|
91
|
|
| Accumulated Depreciation |
7
|
6
|
6
|
7
|
7
|
8
|
0
|
9
|
13
|
17
|
23
|
28
|
36
|
42
|
51
|
|
| Intangible Assets |
7
|
9
|
9
|
9
|
10
|
10
|
11
|
12
|
14
|
16
|
17
|
19
|
19
|
18
|
8
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
97
|
273
|
139
|
236
|
72
|
17
|
332
|
58
|
210
|
257
|
176
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
|
| Total Assets |
22
N/A
|
12
-48%
|
87
+646%
|
68
-22%
|
207
+205%
|
429
+107%
|
390
-9%
|
577
+48%
|
670
+16%
|
703
+5%
|
838
+19%
|
846
+1%
|
965
+14%
|
952
-1%
|
875
-8%
|
|
| Liabilities | ||||||||||||||||
| Accounts Payable |
2
|
1
|
3
|
2
|
6
|
4
|
7
|
4
|
10
|
9
|
14
|
10
|
14
|
17
|
11
|
|
| Accrued Liabilities |
1
|
1
|
1
|
2
|
4
|
7
|
6
|
10
|
11
|
20
|
19
|
23
|
27
|
22
|
38
|
|
| Short-Term Debt |
19
|
21
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
28
|
48
|
43
|
|
| Other Current Liabilities |
5
|
2
|
3
|
2
|
33
|
96
|
60
|
40
|
45
|
93
|
37
|
30
|
5
|
0
|
4
|
|
| Total Current Liabilities |
26
|
26
|
8
|
6
|
43
|
106
|
73
|
54
|
67
|
121
|
71
|
64
|
74
|
87
|
96
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
162
|
115
|
76
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
0
|
|
| Other Liabilities |
7
|
6
|
6
|
2
|
1
|
8
|
1
|
1
|
11
|
10
|
34
|
55
|
67
|
75
|
68
|
|
| Total Liabilities |
33
N/A
|
31
-6%
|
14
-56%
|
9
-38%
|
45
+424%
|
115
+158%
|
74
-36%
|
55
-25%
|
77
+40%
|
131
+70%
|
105
-20%
|
119
+13%
|
303
+155%
|
274
-10%
|
240
-13%
|
|
| Equity | ||||||||||||||||
| Common Stock |
147
|
147
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Retained Earnings |
159
|
167
|
228
|
244
|
262
|
238
|
253
|
323
|
296
|
366
|
283
|
338
|
471
|
704
|
796
|
|
| Additional Paid In Capital |
1
|
1
|
301
|
303
|
424
|
553
|
571
|
845
|
888
|
938
|
1 018
|
1 072
|
1 131
|
1 382
|
1 429
|
|
| Other Equity |
0
|
0
|
0
|
0
|
1
|
1
|
2
|
1
|
1
|
0
|
2
|
7
|
1
|
1
|
2
|
|
| Total Equity |
11
N/A
|
20
-79%
|
74
N/A
|
59
-19%
|
162
+174%
|
314
+93%
|
317
+1%
|
522
+65%
|
593
+14%
|
572
-4%
|
734
+28%
|
728
-1%
|
662
-9%
|
678
+2%
|
636
-6%
|
|
| Total Liabilities & Equity |
22
N/A
|
12
-48%
|
87
+646%
|
68
-22%
|
207
+205%
|
429
+107%
|
390
-9%
|
577
+48%
|
670
+16%
|
703
+5%
|
838
+19%
|
846
+1%
|
965
+14%
|
952
-1%
|
875
-8%
|
|
| Shares Outstanding | ||||||||||||||||
| Common Shares Outstanding |
27
|
27
|
31
|
31
|
41
|
47
|
47
|
56
|
57
|
58
|
59
|
60
|
61
|
70
|
72
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
